Active Ingredient History
Alemtuzumab, sold under the brand names Campath and Lemtrada among others, is a medication used to treat chronic lymphocytic leukemia and multiple sclerosis. In chronic lymphocytic leukemia, it has been used as both a first line and second line treatment. It is given by injection into a vein. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acne Vulgaris (Phase 2)
Adenocarcinoma, Clear Cell (Phase 1)
Adrenoleukodystrophy (Phase 2)
Agammaglobulinemia (Phase 2)
Alemtuzumab (Phase 2)
Allergy and Immunology (Phase 1/Phase 2)
Allografts (Phase 1/Phase 2)
alpha-Mannosidosis (Phase 2)
Amputation, Surgical (Phase 2/Phase 3)
Amputation, Traumatic (Phase 2/Phase 3)
Anemia (Phase 2)
Anemia, Aplastic (Phase 2/Phase 3)
Anemia, Diamond-Blackfan (Phase 2/Phase 3)
Anemia, Hemolytic, Autoimmune (Phase 2/Phase 3)
Anemia, Hemolytic, Congenital (Phase 2)
Anemia, Sickle Cell (Phase 3)
Arthritis, Juvenile (Phase 2)
Arthritis, Rheumatoid (Phase 1)
Aspartylglucosaminuria (Phase 2)
Autoimmune Diseases (Phase 2)
Autoimmune Lymphoproliferative Syndrome (Phase 2)
beta-Thalassemia (Phase 2)
Blood (Phase 2)
Bone Marrow Failure Disorders (Phase 2)
Bone Marrow Transplantation (Phase 2)
Breast Neoplasms (Phase 2)
Burkitt Lymphoma (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Cerebellum (Phase 2)
Chediak-Higashi Syndrome (Phase 2/Phase 3)
Common Variable Immunodeficiency (Phase 2)
Congenital Bone Marrow Failure Syndromes (Phase 2)
Crohn Disease (Phase 2)
Deficiency Diseases (Phase 1/Phase 2)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 2)
DiGeorge Syndrome (Phase 2)
Drugs, Investigational (Phase 2)
Dyskeratosis Congenita (Phase 2/Phase 3)
Endoscopy (Phase 2)
Epidermolysis Bullosa (Early Phase 1)
Fallopian Tube Neoplasms (Phase 1)
Fanconi Anemia (Phase 1/Phase 2)
Fucosidosis (Phase 2)
Gangliosidosis, GM1 (Phase 2)
General Surgery (Phase 2/Phase 3)
Genital Diseases, Male (Phase 1)
Gestational Trophoblastic Disease (Phase 2)
Graft Rejection (Phase 4)
Graft vs Host Disease (Phase 2/Phase 3)
Granuloma (Early Phase 1)
Granulomatosis with Polyangiitis (Phase 4)
Granulomatous Disease, Chronic (Phase 4)
Hair (Phase 2/Phase 3)
Hamartoma (Phase 1)
Heart Diseases (Phase 4)
Hematologic Diseases (Phase 2/Phase 3)
Hematologic Neoplasms (Phase 2)
Hematopoietic Stem Cell Transplantation (Phase 2)
Hemoglobinopathies (Phase 2)
Hemoglobinuria, Paroxysmal (Phase 2)
Hepatitis C (Phase 2)
Hepatitis C, Chronic (Phase 2)
Histiocytosis (Phase 2)
Histiocytosis, Langerhans-Cell (Phase 2/Phase 3)
Hodgkin Disease (Phase 2)
Hypertension, Pulmonary (Phase 2)
Idiopathic Pulmonary Fibrosis (Phase 1/Phase 2)
Immunoblastic Lymphadenopathy (Phase 3)
Immunoglobulin M (Phase 2)
Immunologic Deficiency Syndromes (Phase 2)
Immunosuppression Therapy (Phase 2)
Inflammation (Phase 4)
Intestinal Neoplasms (Phase 1)
Intraocular Lymphoma (Phase 2)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 4)
Kidney Transplantation (Phase 4)
Leukemia (Phase 3)
Leukemia, B-Cell (Phase 2)
Leukemia, Erythroblastic, Acute (Phase 2)
Leukemia, Hairy Cell (Phase 2)
Leukemia, Large Granular Lymphocytic (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia-Lymphoma, Adult T-Cell (Phase 2)
Leukemia, Mast-Cell (Phase 2)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2/Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Leukemia, Prolymphocytic (Phase 2)
Leukemia, Prolymphocytic, T-Cell (Phase 2)
Leukodystrophy, Globoid Cell (Phase 2)
Leukodystrophy, Metachromatic (Phase 2)
Liver Diseases (Phase 2)
Liver Failure (Phase 2)
Liver Transplantation (Phase 3)
Living Donors (Phase 4)
Lung Diseases, Interstitial (Phase 2)
Lupus Erythematosus, Systemic (Phase 1)
Lymphohistiocytosis, Hemophagocytic (Phase 2/Phase 3)
Lymphoid Tissue (Phase 2/Phase 3)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 1)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Extranodal NK-T-Cell (Phase 3)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 3)
Lymphoma, T-Cell, Peripheral (Phase 2)
Lymphomatoid Granulomatosis (Phase 2)
Lymphoproliferative Disorders (Phase 2/Phase 3)
Melanoma (Phase 1)
Metabolic Diseases (Phase 2)
Metabolism, Inborn Errors (Phase 2)
Microscopic Polyangiitis (Phase 4)
Mucolipidoses (Phase 2)
Mucopolysaccharidoses (Phase 2)
Mucopolysaccharidosis I (Phase 2)
Mucopolysaccharidosis II (Phase 2)
Mucopolysaccharidosis III (Phase 2)
Mucopolysaccharidosis VI (Phase 2)
Mucopolysaccharidosis VII (Phase 2)
Multiple Myeloma (Phase 2)
Multiple Sclerosis, Relapsing-Remitting (Phase 4)
Mycosis Fungoides (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 2)
Myositis, Inclusion Body (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Germ Cell and Embryonal (Phase 1)
Neoplasms, Neuroepithelial (Early Phase 1)
Neuroblastoma (Phase 2)
Neutropenia (Phase 2/Phase 3)
Neutrophils (Phase 2)
Niemann-Pick Disease, Type B (Phase 2)
Niemann-Pick Disease, Type C (Phase 2)
Organ Transplantation (Phase 2/Phase 3)
Osteopetrosis (Phase 2/Phase 3)
Osteoporosis (Phase 3)
Ovarian Neoplasms (Phase 2)
Pancytopenia (Phase 2)
Paraproteinemias (Phase 1/Phase 2)
Penis (Phase 2/Phase 3)
Peroxisomal Disorders (Phase 2)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2/Phase 3)
Preleukemia (Phase 1/Phase 2)
Primary Immunodeficiency Diseases (Phase 2)
Primary Myelofibrosis (Phase 2/Phase 3)
Pseudomyxoma Peritonei (Phase 2)
Pulmonary Disease, Chronic Obstructive (Phase 1/Phase 2)
Purpura, Thrombocytopenic, Idiopathic (Phase 2/Phase 3)
Red-Cell Aplasia, Pure (Phase 2)
Renal Insufficiency (Phase 4)
Rhabdoid Tumor (Phase 1)
Rhabdomyosarcoma (Phase 1)
Sandhoff Disease (Phase 2)
Sarcoma, Ewing (Phase 1)
Scleroderma, Diffuse (Phase 2)
Scleroderma, Systemic (Phase 2)
Severe Combined Immunodeficiency (Phase 2)
Sezary Syndrome (Phase 2)
Shwachman-Diamond Syndrome (Phase 2/Phase 3)
Sphingolipidoses (Phase 2)
Squamous Intraepithelial Lesions (Phase 2)
Stem Cell Transplantation (Phase 1/Phase 2)
Tay-Sachs Disease (Phase 2)
Testicular Neoplasms (Phase 2)
Thalassemia (Phase 2/Phase 3)
Thrombocytopenia (Phase 2)
Urological Manifestations (Phase 1)
Urologic Surgical Procedures, Male (Phase 2/Phase 3)
Vasculitis (Phase 4)
Waldenstrom Macroglobulinemia (Phase 2)
Wilms Tumor (Phase 1)
Wiskott-Aldrich Syndrome (Phase 2)
Wolman Disease (Phase 2)
Wounds and Injuries (Phase 2/Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
